The conference was held by the International Pharmaceutical Research Centre (IPRC) in Amman- Jordan, with the IPRC supervision and organization and in accompany with: the American Association of Pharmaceutical Scientists (AAPS), the European Federation for Pharmaceutical Sciences (EUFEPS), the International Pharmaceutical Federation (FIP) and the Turkish Pharmaceutical Technology Scientists Association (TUFTAD).

The conference was inaugurated by Prof. Naji Najib, IPRC Chairman, welcoming the audience and praising the role of the participated international federations in preparing and supporting the conference to be a platform for the experiences and knowledge exchange in the field of BE and clinical –related fields. He also mentioned that the Conference is considered as one of the most important events planned for this year in the region; due to the presence of and the participation of international, well-known and keynote speakers in the field of clinical studies.

The event was attended by a number of regulatory and science key professionals as well as a remarkable participation of the pharmaceutical industry and academia to share experiences, perspectives, insights and the latest regulation and technical development.

While from An-Najah, the participants were: Dr. Amjad Hussein, the Director of “Analysis, Poison Control and Calibration Centre (APCC)” and Assistant Professor at the Faculty of Medicine and Health Sciences; Prof. Abdel Naser Zaid, the Director of the Pharmacy Department - Faculty of Medicine & Health Sciences and a member of the Scientific Advisory Council of the Conference and Dr. Raeda Mustafa, the Technical & Regulatory Department Head at An-Najah BioSciences Unit (NBU) - APCC Centre.

Prof. Zaid gave a lecture to discuss a paper titled: “Food effect: The combined effect of media pH and viscosity on the gastrointestinal absorption of Ciprofloxacin tablet”; where he explained the clinical effects of drug-food interactions when taking Ciprofloxacin with Jute soap, and there should be a necessity to take the subject seriously in order to reduce differences in the drug bioavailability.

Furthermore, Dr. Mustafa presented a lecture titled: "Good Clinical Practice (GCP) in Bioequivalence Studies"; where she elaborated on the importance of GCP in carrying out clinical studies in general and in the BE studies in particular. She also discussed the latest amendments and updates on the GCP guidelines and that are applicable in those studies.